Health
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge | NEJM – nejm.org
Correspondence from The New England Journal of Medicine — Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge
After emergency use of the mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine was authorized, the observer-blinded, pivotal Coronavirus Efficacy (COVE) trial was amended on December 23, 2020, to include an open-label phase in…
Continue Reading
-
Noosa News24 hours agoADF to introduce billion-dollar drone dome over Brisbane 2032
-
General21 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
General20 hours agoTwo men involved in fatal helicopter accident charged over stealing crocodile eggs from Kakadu National Park
-
Business23 hours agoMacquarie predicts more than 40% upside for this ASX 200 stock